AVTX
Price
$11.60
Change
+$1.44 (+14.17%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
152.57M
XLO
Price
$0.70
Change
-$0.02 (-2.78%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
36.27M
62 days until earnings call
Interact to see
Advertisement

AVTX vs XLO

Header iconAVTX vs XLO Comparison
Open Charts AVTX vs XLOBanner chart's image
Avalo Therapeutics
Price$11.60
Change+$1.44 (+14.17%)
Volume$12.37K
Capitalization152.57M
Xilio Therapeutics
Price$0.70
Change-$0.02 (-2.78%)
Volume$1.5K
Capitalization36.27M
AVTX vs XLO Comparison Chart in %
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. XLO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and XLO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AVTX: $10.16 vs. XLO: $0.72)
Brand notoriety: AVTX and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 32% vs. XLO: 49%
Market capitalization -- AVTX: $152.57M vs. XLO: $36.27M
AVTX [@Biotechnology] is valued at $152.57M. XLO’s [@Biotechnology] market capitalization is $36.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than XLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 6 bullish TA indicator(s).

  • AVTX’s TA Score: 4 bullish, 5 bearish.
  • XLO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, XLO is a better buy in the short-term than AVTX.

Price Growth

AVTX (@Biotechnology) experienced а +8.78% price change this week, while XLO (@Biotechnology) price change was +3.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

XLO is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($153M) has a higher market cap than XLO($36.3M). AVTX YTD gains are higher at: 36.743 vs. XLO (-24.817). XLO has higher annual earnings (EBITDA): -55.02M vs. AVTX (-59.78M). XLO has more cash in the bank: 122M vs. AVTX (113M). AVTX has less debt than XLO: AVTX (679K) vs XLO (7.57M). XLO has higher revenues than AVTX: XLO (15M) vs AVTX (441K).
AVTXXLOAVTX / XLO
Capitalization153M36.3M421%
EBITDA-59.78M-55.02M109%
Gain YTD36.743-24.817-148%
P/E Ratio1.77N/A-
Revenue441K15M3%
Total Cash113M122M93%
Total Debt679K7.57M9%
FUNDAMENTALS RATINGS
AVTX: Fundamental Ratings
AVTX
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTXXLO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THGHY0.280.01
+2.82%
THG Holdings PLC.
IFLXF0.90N/A
N/A
Imaflex Inc
NNDNF21.80N/A
N/A
Nidec Corp.
MDIKF18.29N/A
N/A
Modec Inc.
SENR0.03N/A
-13.79%
Strategic Environmental & Energy Resources, Inc.

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-3.74%
FGEN - AVTX
57%
Loosely correlated
-5.43%
MEOBF - AVTX
46%
Loosely correlated
N/A
MRSN - AVTX
37%
Loosely correlated
+2.01%
PGEN - AVTX
34%
Loosely correlated
-4.00%
BDRX - AVTX
32%
Poorly correlated
+0.38%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and CRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-0.80%
CRMD - XLO
31%
Poorly correlated
-6.57%
AXON - XLO
31%
Poorly correlated
+0.67%
VKTX - XLO
30%
Poorly correlated
-1.12%
AVTX - XLO
27%
Poorly correlated
-3.74%
CBIO - XLO
26%
Poorly correlated
+3.48%
More